Dong-A Socio Holdings corrects subsidiary on KRW 7.54 billion drug contract filing, extends disclosure hold to Oct. 7, 2029

Bitget2026/09/30 10:31

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Dong-A Socio Holdings issued a correction to its April 20 disclosure on a subsidiary supply contract.
Subsidiary name was revised to BTGen from STGenBio.
Confidentiality hold deadline was extended to Oct. 7, 2029 under counterparty terms.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dong-A Socio Holdings Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260930801114), on September 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Dong-A Socio Holdings corrects subsidiary on KRW 7.54 billion drug contract filing, extends disclosure hold to Oct. 7, 2029

You may also like

Crypto prices